Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1981 Mar;57(665):150–152. doi: 10.1136/pgmj.57.665.150

Relationships of the platelet aggregate ratio to serum cholesterol concentration, smoking and age

James W Davis, H Daniel Lewis Jr, Phyllis E Phillips, Rebecca F Davis
PMCID: PMC2424869  PMID: 7329876

Abstract

The platelet aggregate ratio has been found to be decreased in some patients with vascular diseases suggesting the presence of increased circulating platelet aggregates. It has also been reported that hypercholesterolaemia is associated with an enhanced response of platelets to aggregating agents in platelet-rich plasma. The primary purpose of this investigation was to determine correlation of the platelet aggregate ratio with the serum cholesterol concentration of men with vascular diseases. For 52 men referred because of known or suspected coronary artery disease, cerebrovascular disease, or venous thromboembolism, the correlation coefficient of 0·06 suggested that the serum cholesterol concentration within the range observed (135-360 mg/dl) was not a factor influencing the platelet aggregate ratio. There was not a statistically significant difference between the mean platelet aggregate ratios or the mean serum cholesterol concentrations of the 21 non-smokers and the 31 smokers studied. A correlation coefficient of 0·03 between the platelet aggregate ratio and age of the patient suggested that the platelet aggregate ratio was independent of age in men with occlusive vascular diseases.

Full text

PDF
152

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carvalho A. C., Colman R. W., Lees R. S. Platelet function in hyperlipoproteinemia. N Engl J Med. 1974 Feb 21;290(8):434–438. doi: 10.1056/NEJM197402212900805. [DOI] [PubMed] [Google Scholar]
  2. Davis J. W., Davis R. F. Acute effect of tobacco cigarette smoking on the platelet aggregate ratio. Am J Med Sci. 1979 Sep-Oct;278(2):139–143. doi: 10.1097/00000441-197909000-00004. [DOI] [PubMed] [Google Scholar]
  3. Davis J. W., Davis R. F. Prevention of cigarette smoking-induced platelet aggregate formation by aspirin. Arch Intern Med. 1981 Feb;141(2):206–207. [PubMed] [Google Scholar]
  4. Dougherty J. H., Jr, Levy D. E., Weksler B. B. Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease. Lancet. 1977 Apr 16;1(8016):821–824. doi: 10.1016/s0140-6736(77)92774-x. [DOI] [PubMed] [Google Scholar]
  5. Enger S. C., Herbjørnsen K., Erikssen J., Fretland A. High density lipoproteins (HDL) and physical activity: the influence of physical exercise, age and smoking on HDL-cholesterol and the HDL-/total cholesterol ratio. Scand J Clin Lab Invest. 1977 May;37(3):251–255. doi: 10.3109/00365517709091490. [DOI] [PubMed] [Google Scholar]
  6. Erikssen J., Hellem A., Stormorken H. Chronic effect of smoking on platelet count and "platelet adhesiveness" in presumably healthy middle-aged men. Thromb Haemost. 1977 Oct 31;38(3):606–611. [PubMed] [Google Scholar]
  7. Gjesdal K. Platelet function and plasma free fatty acids during acute myocardial infarction and severe angina pectoris. Scand J Haematol. 1976 Sep;17(3):205–212. doi: 10.1111/j.1600-0609.1976.tb01176.x. [DOI] [PubMed] [Google Scholar]
  8. Guyton J. R., Willerson J. T. Peripheral venous platelet aggregates in patients with unstable angina pectoris and acute myocardial infarction. Angiology. 1977 Oct;28(10):695–701. doi: 10.1177/000331977702801006. [DOI] [PubMed] [Google Scholar]
  9. KARVONEN M., ORMA E., KEYS A., FIDANZA F., BROZEK J. Cigarette smoking, serum-cholesterol, blood-pressure, and body fatness; observations in Finland. Lancet. 1959 Mar 7;1(7071):492–494. doi: 10.1016/s0140-6736(59)91022-0. [DOI] [PubMed] [Google Scholar]
  10. Kaplan K. L., Broekman M. J., Chernoff A., Lesznik G. R., Drillings M. Platelet alpha-granule proteins: studies on release and subcellular localization. Blood. 1979 Apr;53(4):604–618. [PubMed] [Google Scholar]
  11. Mehta P., Mehta J. Platelet function studies in coronary artery disease. V. Evidence for enhanced platelet microthrombus formation activity in acute myocardial infarction. Am J Cardiol. 1979 Apr;43(4):757–760. doi: 10.1016/0002-9149(79)90075-4. [DOI] [PubMed] [Google Scholar]
  12. Pozner H., Billimoria J. D. Effect of smoking on blood-clotting and lipid and lipoprotein levels. Lancet. 1970 Jun 20;760(1):1318–1321. doi: 10.1016/s0140-6736(70)91912-4. [DOI] [PubMed] [Google Scholar]
  13. Prazich J. A., Rapaport S. I., Samples J. R., Engler R. Platelet aggregate ratios--standardization of technique and test results in patients with myocardial ischemia and patients with cerebrovascular disease. Thromb Haemost. 1977 Oct 31;38(3):597–605. [PubMed] [Google Scholar]
  14. Rohrer T. F., Pfister B., Weber C., Imhof P. R., Stucki P. Quantitative changes in platelet aggregation due to physiological and pathological factors and medication. Blut. 1978 Jan 20;36(1):21–26. doi: 10.1007/BF01002116. [DOI] [PubMed] [Google Scholar]
  15. Rohrer T. F., Pfister B., Weber C., Imhof P. R., Stucki P. Validity of the Wu-Hoak method for the quantitative determination of platelet aggregation in vivo. Blut. 1978 Jan 20;36(1):15–20. doi: 10.1007/BF01002115. [DOI] [PubMed] [Google Scholar]
  16. Salem H. H., Koutts J., Firkin B. G. Circulating platelet aggregates in ischaemic heart disease and their correlation to platelet life span. Thromb Res. 1980 Mar 1;17(5):707–711. doi: 10.1016/0049-3848(80)90373-4. [DOI] [PubMed] [Google Scholar]
  17. THOMAS C. B. Familial and epidemiologic aspects of coronary disease and hypertension. J Chronic Dis. 1958 Mar;7(3):198–208. doi: 10.1016/0021-9681(58)90026-2. [DOI] [PubMed] [Google Scholar]
  18. Wu K. K., Armstrong M. L., Hoak J. C., Megan M. B. Platelet aggregates in hypercholesterolemic rhesus monkeys. Thromb Res. 1975 Dec;7(6):917–924. doi: 10.1016/0049-3848(75)90095-x. [DOI] [PubMed] [Google Scholar]
  19. Wu K. K., Barnes R. W., Hoak J. C. Platelet hyperaggregability in idiopathic recurrent deep vein thrombosis. Circulation. 1976 Apr;53(4):687–691. doi: 10.1161/01.cir.53.4.687. [DOI] [PubMed] [Google Scholar]
  20. Wu K. K., Hoak J. C. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet. 1974 Oct 19;2(7886):924–926. doi: 10.1016/s0140-6736(74)91131-3. [DOI] [PubMed] [Google Scholar]
  21. Wu K. K., Hoak J. C. Increased platelet aggregates in patients with transient ischemic attacks. Stroke. 1975 Sep-Oct;6(5):521–524. doi: 10.1161/01.str.6.5.521. [DOI] [PubMed] [Google Scholar]
  22. Wu K. K. Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann Intern Med. 1978 Jan;88(1):7–11. doi: 10.7326/0003-4819-88-1-7. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES